160 related articles for article (PubMed ID: 27356891)
21. The Fanconi anemia DNA damage repair pathway in the spotlight for germline predisposition to colorectal cancer.
Esteban-Jurado C; Franch-Expósito S; Muñoz J; Ocaña T; Carballal S; López-Cerón M; Cuatrecasas M; Vila-Casadesús M; Lozano JJ; Serra E; Beltran S; Brea-Fernández A; Ruiz-Ponte C; Castells A; Bujanda L; Garre P; Caldés T; Cubiella J; Balaguer F; Castellví-Bel S
Eur J Hum Genet; 2016 Oct; 24(10):1501-5. PubMed ID: 27165003
[TBL] [Abstract][Full Text] [Related]
22. Systematic search for rare variants in Finnish early-onset colorectal cancer patients.
Tanskanen T; Gylfe AE; Katainen R; Taipale M; Renkonen-Sinisalo L; Järvinen H; Mecklin JP; Böhm J; Kilpivaara O; Pitkänen E; Palin K; Vahteristo P; Tuupanen S; Aaltonen LA
Cancer Genet; 2015; 208(1-2):35-40. PubMed ID: 25749350
[TBL] [Abstract][Full Text] [Related]
23. Germline pathogenic variant spectrum in 25 cancer susceptibility genes in Turkish breast and colorectal cancer patients and elderly controls.
Akcay IM; Celik E; Agaoglu NB; Alkurt G; Kizilboga Akgun T; Yildiz J; Enc F; Kir G; Canbek S; Kilic A; Zemheri E; Ezberci F; Ozcelik M; Dinler Doganay G; Doganay L
Int J Cancer; 2021 Jan; 148(2):285-295. PubMed ID: 32658311
[TBL] [Abstract][Full Text] [Related]
24. Survey of germline variants in cancer-associated genes in young adults with colorectal cancer.
Mikaeel RR; Young JP; Li Y; Smith E; Horsnell M; Uylaki W; Tapia Rico G; Poplawski NK; Hardingham JE; Tomita Y; Townsend AR; Feng J; Zibat A; Kaulfuß S; Müller C; Yigit G; Wollnik B; Price TJ
Genes Chromosomes Cancer; 2022 Feb; 61(2):105-113. PubMed ID: 34761457
[TBL] [Abstract][Full Text] [Related]
25. Statewide Retrospective Review of Familial Pancreatic Cancer in Delaware, and Frequency of Genetic Mutations in Pancreatic Cancer Kindreds.
Catts ZA; Baig MK; Milewski B; Keywan C; Guarino M; Petrelli N
Ann Surg Oncol; 2016 May; 23(5):1729-35. PubMed ID: 26727920
[TBL] [Abstract][Full Text] [Related]
26. Prevalence and Spectrum of Germline Cancer Susceptibility Gene Mutations Among Patients With Early-Onset Colorectal Cancer.
Pearlman R; Frankel WL; Swanson B; Zhao W; Yilmaz A; Miller K; Bacher J; Bigley C; Nelsen L; Goodfellow PJ; Goldberg RM; Paskett E; Shields PG; Freudenheim JL; Stanich PP; Lattimer I; Arnold M; Liyanarachchi S; Kalady M; Heald B; Greenwood C; Paquette I; Prues M; Draper DJ; Lindeman C; Kuebler JP; Reynolds K; Brell JM; Shaper AA; Mahesh S; Buie N; Weeman K; Shine K; Haut M; Edwards J; Bastola S; Wickham K; Khanduja KS; Zacks R; Pritchard CC; Shirts BH; Jacobson A; Allen B; de la Chapelle A; Hampel H;
JAMA Oncol; 2017 Apr; 3(4):464-471. PubMed ID: 27978560
[TBL] [Abstract][Full Text] [Related]
27. Exome sequencing in 51 early onset non-familial CRC cases.
Thutkawkorapin J; Lindblom A; Tham E
Mol Genet Genomic Med; 2019 May; 7(5):e605. PubMed ID: 30809968
[TBL] [Abstract][Full Text] [Related]
28. Association Between Germline Mutations in BRF1, a Subunit of the RNA Polymerase III Transcription Complex, and Hereditary Colorectal Cancer.
Bellido F; Sowada N; Mur P; Lázaro C; Pons T; Valdés-Mas R; Pineda M; Aiza G; Iglesias S; Soto JL; Urioste M; Caldés T; Balbín M; Blay P; Rueda D; Durán M; Valencia A; Moreno V; Brunet J; Blanco I; Navarro M; Calin GA; Borck G; Puente XS; Capellá G; Valle L
Gastroenterology; 2018 Jan; 154(1):181-194.e20. PubMed ID: 28912018
[TBL] [Abstract][Full Text] [Related]
29. Inherited predisposition to pancreatic adenocarcinoma: role of family history and germ-line p16, BRCA1, and BRCA2 mutations.
Lal G; Liu G; Schmocker B; Kaurah P; Ozcelik H; Narod SA; Redston M; Gallinger S
Cancer Res; 2000 Jan; 60(2):409-16. PubMed ID: 10667595
[TBL] [Abstract][Full Text] [Related]
30. Hereditary breast cancer; Genetic penetrance and current status with BRCA.
Mahdavi M; Nassiri M; Kooshyar MM; Vakili-Azghandi M; Avan A; Sandry R; Pillai S; Lam AK; Gopalan V
J Cell Physiol; 2019 May; 234(5):5741-5750. PubMed ID: 30552672
[TBL] [Abstract][Full Text] [Related]
31. Somatic molecular changes and histo-pathological features of colorectal cancer in Tunisia.
Aissi S; Buisine MP; Zerimech F; Kourda N; Moussa A; Manai M; Porchet N
World J Gastroenterol; 2013 Aug; 19(32):5286-94. PubMed ID: 23983431
[TBL] [Abstract][Full Text] [Related]
32. Detection of germline variants with pathogenic potential in 48 patients with familial colorectal cancer by using whole exome sequencing.
Singh AK; Talseth-Palmer B; Xavier A; Scott RJ; Drabløs F; Sjursen W
BMC Med Genomics; 2023 Jun; 16(1):126. PubMed ID: 37296477
[TBL] [Abstract][Full Text] [Related]
33. Novel mutations in actionable breast cancer genes by targeted sequencing in an ethnically homogenous cohort.
Akter H; Sultana N; Martuza N; Siddiqua A; Dity NJ; Rahaman MA; Samara B; Sayeed A; Basiruzzaman M; Rahman MM; Rashidul Hoq M; Amin MR; Baqui MA; Woodbury-Smith M; Uddin KMF; Islam SS; Awwal R; Berdiev BK; Uddin M
BMC Med Genet; 2019 Sep; 20(1):150. PubMed ID: 31477031
[TBL] [Abstract][Full Text] [Related]
34. Evaluating the breast cancer predisposition role of rare variants in genes associated with low-penetrance breast cancer risk SNPs.
Li N; Rowley SM; Thompson ER; McInerny S; Devereux L; Amarasinghe KC; Zethoven M; Lupat R; Goode D; Li J; Trainer AH; Gorringe KL; James PA; Campbell IG
Breast Cancer Res; 2018 Jan; 20(1):3. PubMed ID: 29316957
[TBL] [Abstract][Full Text] [Related]
35.
Martín-Morales L; Garre P; Lorca V; Cazorla M; Llovet P; Bando I; García-Barberan V; González-Morales ML; Esteban-Jurado C; de la Hoya M; Castellví-Bel S; Caldés T
Cancer Prev Res (Phila); 2021 Feb; 14(2):185-194. PubMed ID: 33115781
[TBL] [Abstract][Full Text] [Related]
36. Eleven candidate susceptibility genes for common familial colorectal cancer.
Gylfe AE; Katainen R; Kondelin J; Tanskanen T; Cajuso T; Hänninen U; Taipale J; Taipale M; Renkonen-Sinisalo L; Järvinen H; Mecklin JP; Kilpivaara O; Pitkänen E; Vahteristo P; Tuupanen S; Karhu A; Aaltonen LA
PLoS Genet; 2013; 9(10):e1003876. PubMed ID: 24146633
[TBL] [Abstract][Full Text] [Related]
37. Activating mutation in MET oncogene in familial colorectal cancer.
Neklason DW; Done MW; Sargent NR; Schwartz AG; Anton-Culver H; Griffin CA; Ahnen DJ; Schildkraut JM; Tomlinson GE; Strong LC; Miller AR; Stopfer JE; Burt RW
BMC Cancer; 2011 Oct; 11():424. PubMed ID: 21970370
[TBL] [Abstract][Full Text] [Related]
38. Identification of Novel Candidate Genes for Early-Onset Colorectal Cancer Susceptibility.
de Voer RM; Hahn MM; Weren RD; Mensenkamp AR; Gilissen C; van Zelst-Stams WA; Spruijt L; Kets CM; Zhang J; Venselaar H; Vreede L; Schubert N; Tychon M; Derks R; Schackert HK; Geurts van Kessel A; Hoogerbrugge N; Ligtenberg MJ; Kuiper RP
PLoS Genet; 2016 Feb; 12(2):e1005880. PubMed ID: 26901136
[TBL] [Abstract][Full Text] [Related]
39. Case Review: Whole-Exome Sequencing Analyses Identify Carriers of a Known Likely Pathogenic Intronic
Alenezi WM; Fierheller CT; Revil T; Serruya C; Mes-Masson AM; Foulkes WD; Provencher D; El Haffaf Z; Ragoussis J; Tonin PN
Genes (Basel); 2022 Apr; 13(4):. PubMed ID: 35456503
[TBL] [Abstract][Full Text] [Related]
40. Tumor sequencing is useful to refine the analysis of germline variants in unexplained high-risk breast cancer families.
Van Marcke C; Helaers R; De Leener A; Merhi A; Schoonjans CA; Ambroise J; Galant C; Delrée P; Rothé F; Bar I; Khoury E; Brouillard P; Canon JL; Vuylsteke P; Machiels JP; Berlière M; Limaye N; Vikkula M; Duhoux FP
Breast Cancer Res; 2020 Apr; 22(1):36. PubMed ID: 32295625
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
